GENESYS NSE filing

Genesys International Board Approves New Auditors and ESOP Scheme

The RealCase readMedium impact Neutral

Genesys International's Board approved M/s. G. K. Choksi & Co. as new Statutory Auditors for five years. The "Genesys ESOP Scheme – 2026" was approved, proposing up to 30 lakh stock options. An adjustment to ESOP 2022 granted 1,82,640 additional options. M/s. XAG & Co. appointed as Internal Auditors. The 44th AGM is on September 30, 2026.

Why it matters

The appointment of new statutory auditors and the introduction of an ESOP scheme are significant corporate actions that can impact governance and employee motivation. The AGM date is also a key event for shareholders.

The market read

The announcement details routine corporate actions such as auditor changes and ESOP scheme approvals, which are standard procedures and do not inherently indicate a positive or negative shift in the company's performance or outlook.

Genesys International Corporation Limited announced key outcomes from its Board Meeting held on September 02, 2026. The Board approved, subject to shareholder approval, the appointment of M/s. G. K. Choksi & Co. as the new Statutory Auditors for a five-year term, succeeding M/s. MSKA & Associates.

Additionally, the Board sanctioned the introduction of the "Genesys ESOP Scheme – 2026," which proposes to grant up to 30,00,000 stock options to eligible employees. The Board also approved an adjustment to the outstanding options under the Genesys ESOP Scheme – 2022, granting an additional 1,82,640 stock options consequent to the company's rights issue.

In other changes, the Board accepted the resignation of M/s. H.C. Vora & Associates as Internal Auditors, effective September 02, 2026. Concurrently, M/s. XAG & Co. were appointed as the new Internal Auditors for the financial year 2026-27.

The Board also approved the notice for the 44th Annual General Meeting (AGM), scheduled for Friday, September 30, 2026, at 03:30 P.M. IST, to be conducted via Video Conferencing/Other Audio-Visual Means.

Primary source

A plain-language summary of a public exchange filing by Genesys International Corporation Limited. Read the original for the full detail.

View original filing
This is RealCase

Every move, explained.

Expert model portfolios with exact weights, an Active or Hold state on every holding, and a written reason behind every change. In your pocket.

Coming soon toApp StoreComing soon toGoogle Play
100% digital · your money stays in your own broker · your data is secure
RealCase
Your RealCases
Core Compounders
Stocks
13.4%
Flexi Core
Mutual Funds
13.1%
Latest change
ActiveHDFC Bank10% → 14%

“Deposits growing faster than loans again. We add on strength, funded from cash.”

₹0Commission · fee-only